Longwoods Blog



Like other rare diseases, the development of vaccines and drugs to combat Ebola has been stymied by a lack of financial backing to move therapeutics through clinical trials. The patient populations weren’t large enough. That may change given the current crisis. The size of the Ebola problem is changing. It has come from isolated areas into several African metropolises where it is impossible to isolate, and could quickly spread to far-flung regions.

Despite the slow advances, several companies have made strides. Gathered here is a collection of articles highlighting the most innovative research BioWorld has covered in recent years, along with our latest reports.

Also included are relevant articles from Medical Device Daily, the news source of record for the high-tech medical technology industry. This business-focused intelligence service is the flagship publication of BioWorld’s med-tech group. To learn more about how to subscribe to Medical Device Daily, please visit http://www.medicaldevicedaily.com.

Ebola drugs & vaccines in the works

EMA calls for review of investigational drugs as Ebola cases rise – BioWorld Today, September 30, 2014


Current window is closing on the opportunity to control Ebola epidemic – BioWorld Today, September 17, 2014


Worldwide regulators join forces to accelerate testing of Ebola drug candidates – BioWorld Today, September 9, 2014


Experimental Ebola drugs moving into patient trials – BioWorld Today, September 8, 2014


China approves Ebola drug for emergency use – BioWorld Today, September 5, 2014


NIH, MHRA launching human safety studies with Ebola vaccine – BioWorld Today, September 3, 2014


In monkeys, Zmapp works against advanced Ebola, researchers reportBioWorld Today, September 2, 2014

Japan ready to add to global Ebola arsenal with flu drug favipiravirBioWorld Today, August 27, 2014

Newco News: Immunovaccine reports success protecting animals from EbolaBioWorld Today, August 26, 2014

‘Wellcome’ effort to speed development of Ebola drugs, vaccinesBioWorld Today, August 22, 2014

Ebola Outbreak: Experimental drug fights Ebola’s cousin Marburg, even after symptom onsetBioWorld Today, August 21, 2014

Researchers: Up to 30K eligible for Ebola drugs in ‘conservative’ estimateBioWorld Today, August 21, 2014

Fever pitch: Globavir says dengue effort could work in Ebola, both early stageBioWorld Today, August 20, 2014

Drugs that were stalled by sequester are getting a second look in EbolaBioWorld Today, August 14, 2014

WHO: Yes, it’s ethical to use experimental Ebola drugs, vaccinesBioWorld Today, August 13, 2014

Lawmakers hear confidence, despair as Ebola outbreak continues to growBioWorld Today, August 8, 2014

Emory ethics expert: Ebola move ‘easy call,’ but others may not beBioWorld Today, August 8, 2014

Xenex’s germ-zapping robots fight deadly hospital superbugsBioWorld Today, August 8, 2014

FDA grants emergency use authorization for Ebola assayBioWorld Today, August 8, 2014

Death Toll Now Tops 800: As the Ebola death toll rises, Zmapp gets trial by fireBioWorld Today, August 5, 2014


Ebola Prophylactic Works as TreatmentBioWorld Today, August 26, 2013

AVI, Tekmira Rise on Contracts for RNA Drugs Targeting EbolaBioWorld Today, July 19, 2010

Ebola, VP35 LinkBioWorld Today, December 14, 2009

Grant Gives Alnylam $23M For Anti-Ebola Virus WorkBioWorld Today, September 29, 2006

Good For Mice, Good For Macaques: First Ebola/Marburg Vaccine Successfully Jumps SpeciesBioWorld Today, June 10, 2005

How Viruses Become One With Universe: In Membrane Fusion, Ebola Has Novel Way To Skin CatBioWorld Today, April 18, 2005

Crucell Lands EUR21M NIH Contract To Produce Ebola Virus VaccineBioWorld Today, April 20, 2005

This report came from: http://www.bioworld.com/content/special-report-push-contain-ebola-virus


This entry was posted on Wednesday, October 1st, 2014 at 2:35 pm and is filed under Publisher's Page.